Clinically Node-Negative (cN0) clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck
open to eligible people ages 18 years and up
This is a phase 2 pragmatic study at a single site that evaluates the clinical benefit of SLNB in patients with high-risk cSCC and cN0. The primary goal is to evaluate the efficacy of SLNB based on the DFS rate at 2 years post-definitive therapy.
at UC Davis
Our lead scientists for Clinically Node-Negative (cN0) research studies include Andrew Birkeland, MD.
Last updated: